3984 Federal Register / Vol. 80, No. 16 / Monday, January 26, 2015 / Notices 

the public interest and with United 

States obligations under international 

treaties, conventions, or protocols in 

effect on May 1, 1971. The DEA 

investigated the company’s maintenance 

of effective controls against diversion by 

inspecting and testing the company’s 

physical security systems, verifying the 

company’s compliance with state and 

local laws, and reviewing the company’s 

background and history. 

Therefore, pursuant to 21 U.S.C. 

823(a), and in accordance with 21 CFR 

1301.33, the above-named company is 

granted registration as a bulk 

manufacturer of the basic classes of 

controlled substances: 

Controlled substance Schedule 

Methylphenidate (1724) ................ II 

Thebaine (9333) ........................... II 

Poppy Straw Concentrate (9670) II 

Tapentadol (9780) ........................ II 

The company is a contract 

manufacturer. In reference to poppy 

straw concentrate the company will 

manufacture thebaine intermediates for 

sale to its customers for further 

manufacture. No other activity for this 

drug code is authorized for this 

registration. 

Dated: January 9, 2015. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator. 

[FR Doc. 2015–01296 Filed 1–23–15; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Manufacturer of Controlled 

Substances Registration: Chemtos, 

LLC 

ACTION: Notice of registration. 

SUMMARY: Chemtos, LLC applied to be 

registered as a manufacturer of certain 

basic classes of controlled substances. 

The DEA grants Chemtos, LLC 

registration as a manufacturer of those 

controlled substances. 

SUPPLEMENTARY INFORMATION: By notice 

dated August 19, 2014, and published in 

the Federal Register on August 26, 

2014, 79 FR 50948, Chemtos, LLC, 

14101 W. Highway 290, Building 2000B, 

Austin, Texas 78737–9331, applied to 

be registered as a manufacturer of 

certain basic classes of controlled 

substances. No comments or objections 

were submitted to this notice. 

The Drug Enforcement 

Administration (DEA) has considered 

the factors in 21 U.S.C. 823(a) and 

determined that the registration of 

Chemtos, LLC to manufacture the basic 

classes of controlled substances is 

consistent with the public interest and 

with United States obligations under 

international treaties, conventions, or 

protocols in effect on May 1, 1971. The 

DEA investigated the company’s 

maintenance of effective controls 

against diversion by inspecting and 

testing the company’s physical security 

systems, verifying the company’s 

compliance with state and local laws, 

and reviewing the company’s 

background and history. 

Therefore, pursuant to 21 U.S.C. 

823(a), and in accordance with 21 CFR 

1301.33, the above-named company is 

granted registration as a bulk 

manufacturer of the basic classes of 

controlled substances listed: 

Controlled substance Schedule 

Amphetamine (1100) .................... II 

Methamphetamine (1105) ............ II 

Lisdexamfetamine (1205) ............. II 

Methylphenidate (1724) ................ II 

Nabilone (7379) ............................ II 

Phenylacetone (8501) .................. II 

Cocaine (9041) ............................. II 

Codeine (9050) ............................. II 

Etorphine HCl (9059) ................... II 

Dihydrocodeine (9120) ................. II 

Oxycodone (9143) ........................ II 

Hydromorphone (9150) ................ II 

Ecgonine (9180) ........................... II 

Ethylmorphine (9190) ................... II 

Hydrocodone (9193) ..................... II 

Levomethorphan (9210) ............... II 

Levorphanol (9220) ...................... II 

Isomethadone (9226) ................... II 

Meperidine (9230) ........................ II 

Meperidine intermediate-A (9232) II 

Meperidine intermediate-B (9233) II 

Meperidine intermediate-C (9234) II 

Methadone (9250) ........................ II 

Methadone intermediate (9254) ... II 

Morphine (9300) ........................... II 

Thebaine (9333) ........................... II 

Dihydroetorphine (9334) ............... II 

Levo-alphacetylmethadol (9648) .. II 

Oxymorphone (9652) ................... II 

Racemethorphan (9732) .............. II 

Racemorphan (9733) ................... II 

The company plans to manufacture 

small quantities of the listed controlled 

substances in bulk for distribution to its 

customers for use as reference 

standards. 

Dated: January 9, 2015. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator. 

[FR Doc. 2015–01292 Filed 1–23–15; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–392] 

Manufacturer of Controlled 

Substances Registration: Mallinckrodt, 

LLC 

ACTION: Notice of registration. 

SUMMARY: Mallinckrodt, LLC applied to 

be registered as a manufacturer of 

certain basic classes of controlled 

substances. The DEA grants 

Mallinckrodt, LLC registration as a 

manufacturer of those controlled 

substances. 

SUPPLEMENTARY INFORMATION: 

By notice dated May 28, 2014, and 

published in the Federal Register on 

June 3, 2014, 79 FR 31986, 

Mallinckrodt, LLC, 3600 North Second 

Street, St. Louis, Missouri 63147, 

applied to be registered as a 

manufacturer of certain basic classes of 

controlled substances. No comments or 

objections were submitted to this notice. 

The Drug Enforcement 

Administration (DEA) has considered 

the factors in 21 U.S.C. 823(a) and 

determined that the registration of 

Mallinckrodt, LLC to manufacture the 

basic classes of controlled substances is 

consistent with the public interest and 

with United States obligations under 

international treaties, conventions, or 

protocols in effect on May 1, 1971. The 

DEA investigated the company’s 

maintenance of effective controls 

against diversion by inspecting and 

testing the company’s physical security 

systems, verifying the company’s 

compliance with state and local laws, 

and reviewing the company’s 

background and history. 

Therefore, pursuant to 21 U.S.C. 

823(a), and in accordance with 21 CFR 

1301.33, the above-named company is 

granted registration as a bulk 

manufacturer of the basic classes of 

controlled substances: 

Controlled substance Schedule 

Tetrahydrocannabinols (7370) ..... I 

Codeine-N-oxide (9053) ............... I 

Dihydromorphine (9145) ............... I 

Difenoxin (9168) ........................... I 

Morphine-N-oxide (9307) ............. I 

Normorphine (9313) ..................... I 

Norlevorphanol (9634) .................. I 

Amphetamine (1100) .................... II 

Methamphetamine (1105) ............ II 

Methylphenidate (1724) ................ II 

Nabilone (7379) ............................ II 

4-Anilino-N-phenethyl-4-piperidine 

(8333).

II 

Codeine (9050) ............................. II 

Dihydrocodeine (9120) ................. II 


emcdonald on DSK67QTVN1PROD with NOTICES